Evidence map›Paper›PMID 27909990›Full record

ReviewCurrent topics in behavioral neurosciences

Orexin/Hypocretin Signaling.

Jyrki P Kukkonen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current topics in behavioral neurosciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Orexin Receptor Antagonists and Insomnia.Current psychiatry reports · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Daily coordination of orexinergic gating in the rat superior colliculus-Implications for intrinsic clock activities in the visual system.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  20. Orexin receptors in GtoPdb v.2021.3.IUPHAR/BPS guide to pharmacology CITE · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jyrki P KukkonenBiochemistry and Cell Biology, Department of Veterinary Biosciences, University of Helsinki, POB 66, FIN-00014, Helsinki, Finland. jyrki.kukkonen@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orexin/hypocretin peptide (orexin-A and orexin-B) signaling is believed to take place via the two G-protein-coupled receptors (GPCRs), named OX

Indexed as

AnimalsHumansOrexin ReceptorsOrexinsSignal TransductionOrexin ReceptorsOrexinsAdenylyl cyclaseCalciumDiacylglycerol lipaseEndocannabinoidGiGqGsHeterotrimeric G-proteinHypocretinK+ channelNa+/Ca2+-exchangerNon-selective cation channelOrexinOX1 receptorOX2 receptorPhospholipase A2Phospholipase CPhospholipase DProtein kinase C

Identifiers

PMID27909990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.